Special Issue "Molecular Immunology in Bacterial Vaccine Discovery"

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".

Deadline for manuscript submissions: 15 October 2020.

Special Issue Editor

Dr. Rita Berisio
E-Mail Website
Guest Editor
Institute of Biostructures and Bioimaging, CNR, Via Mezzocannone 16, I-80134 Napoli, Italy
Interests: protein structure; crystallography; vaccine; immunology; infectious diseases

Special Issue Information

Dear colleague,

The global threat of antimicrobial resistance (AMR) poses a difficult challenge, as underscored by the World Health Organization, which identifies AMR as one of the three greatest threats to human health. Annual deaths due to AMR-related infections are ~700,000 and projected to rise up to 10 million by 2050. New antibiotics are not a solution, since bacteria promptly adapt and develop new resistance mechanisms. Therefore, there is a strong need to invest in vaccines against AMR infections. This Special Issue offers an open access forum that aims to bring together a collection of original research and review articles addressing multi-disciplinary approaches to unveil various aspects of vaccine development against human bacterial pathogens. It will focus on a panel of pathogens, including ESKAPE pathogens (a group of multidrug-resistant bacteria that are the leading cause of hospital infections globally, which “escape” the biocidal action of antibiotics, e.g., Pseudomonas aeruginosa, Staphylococci, Enterococci) and Mycobacterium tuberculosis, a leading cause of death worldwide. An effort is made to bring together researchers from different countries and to merge complementary approaches, comprising biophysics, biochemistry, immunology, microbiology, and both animal and cell models.

Dr. Rita Berisio
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine
  • infectious disease
  • antimicrobial resistance
  • protein structure

Published Papers

This special issue is now open for submission.
Back to TopTop